2023-06-05 07:31:50 ET
-
Clinical-stage biotechnology company, Chemomab Therapeutics ( NASDAQ: CMMB ) announces that Adi Mor, PhD, co-Founder and former CEO and current Director and Chief Scientific Officer, has been reappointed to the role of CEO, replacing Dale Pfost, PhD.
-
Sigal Fattal, former CFO and current Vice President, Finance, has been reappointed to the role of CFO, replacing Donald Marvin.
-
Current Director Nissim Darvish, MD, PhD, has been appointed Chairman of the Board, replacing Dr. Pfost.
-
All the appointments were effective June 1, 2023.
For further details see:
Chemomab Therapeutics announces key management changes